-
-
-
-
-
-
-
Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash
-
-
5,499 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

